RESUMEN
The in vivo monitoring laboratory (IVM) at Karlsruhe Institute of Technology (KIT), with one whole body counter and three partial-body counters, is an approved lab for individual monitoring according to German regulation. These approved labs are required to prove their competencies by accreditation to ISO/IEC 17025:2005. In 2007 a quality management system (QMS), which was successfully audited and granted accreditation, was set up at the IVM. The system is based on the ISO 9001 certified QMS of the central safety department of the Research Centre Karlsruhe the IVM belonged to at that time. The system itself was set up to be flexible and could be adapted to the recent organisational changes (e.g. founding of KIT and an institute for radiation research) with only minor effort.
Asunto(s)
Monitoreo de Radiación/normas , Protección Radiológica/normas , Radiometría/normas , Gestión de la Calidad Total , Acreditación , Alemania , Humanos , Internet , Laboratorios , Desarrollo de Programa , Control de Calidad , Monitoreo de Radiación/métodos , Protección Radiológica/métodos , Radiometría/métodos , Seguridad , Programas Informáticos , UniversidadesRESUMEN
Essential thrombocythemia (ET) is a heterogeneous disorder. For example, the growth of erythropoietin-independent erythroid colonies, termed "endogenous erythroid colonies (EECs)", has previously been observed in only 50% of ET patients. We have recently described the overexpression of a hematopoietic receptor, PRV-1 (polycythemia rubra vera-1), in patients with polycythemia vera (PV). Here, we compare PRV-1 expression and EEC formation in a cohort of 30 patients with ET; 50% of the ET patients in our cohort displayed EEC growth. Likewise, 50% of the ET patients overexpressed PRV-1. Remarkably, only the 15 ET patients displaying EEC growth showed elevated PRV-1 expression, while the 15 EEC-negative ET patients expressed normal PRV-1 levels. It has previously been reported that EEC-positive ET patients develop PV during long-term follow-up. Here, we show that 40% of the PRV-1-positive patients develop symptoms of PV during the course of their disease. In contrast, none of the 15 PRV-1-negative patients displayed such symptoms (p=0.017). Moreover, PRV-1-positive patients had a significantly higher number of thromboembolic or microcirculatory events (p=0.003). We propose that PRV-1-positive ET comprise a pathophysiologically distinct subgroup of patients, one that is at risk for the development of complications and for the emergence of PV.
Asunto(s)
Isoantígenos/biosíntesis , Glicoproteínas de Membrana/biosíntesis , Policitemia Vera/diagnóstico , ARN Mensajero/biosíntesis , Trombocitemia Esencial/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Northern Blotting , Estudios de Cohortes , Diagnóstico Diferencial , Células Precursoras Eritroides/citología , Células Precursoras Eritroides/patología , Femenino , Proteínas Ligadas a GPI , Expresión Génica , Humanos , Isoantígenos/genética , Masculino , Glicoproteínas de Membrana/genética , Persona de Mediana Edad , Policitemia Vera/sangre , Policitemia Vera/complicaciones , Policitemia Vera/patología , ARN Mensajero/genética , Receptores de Superficie Celular , Estudios Retrospectivos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Supervivencia , Trombocitemia Esencial/sangre , Trombocitemia Esencial/complicaciones , Trombocitemia Esencial/patologíaRESUMEN
Previous repeated inhalation exposure studies revealed two independent organotropic effects of inhaled propineb dust: One was restricted to the lung, the other to muscle weakness of hindlimbs. These effects were believed to be causally related to the principle decomposition products of this type of dithiocarbamate in the biological milieu and related to zinc and carbon disulfide. Two mechanistic 1-wk inhalation studies were performed, each focusing on one of these findings. The 7 x 6-h/day repeated-exposure inhalation study analyzed whether the nature of the response occurring at the alveolar level is "adaptive" or "early adverse" and whether soluble zinc is the causative agent. Groups of 18 female rats were exposed nose-only to mean concentrations of 0, 1.1, 5.5, and 25.8 mg propineb/m(3) and 6.9 mg ZnO/m(3). On postexposure days 1, 3, and 15 the time course of responses was analyzed by bronchoalveolar lavage (BAL), including quantification of Zn and metallothionein (MT) in BAL cells. Clinical evidence of muscular weakness was investigated separately in 20 female Wistar rats exposed to 70 mg propineb/m(3) on 5 consecutive days (6 h/day), followed by a 2-wk postexposure period. Clinical signs, body weights, and feed and water consumption were recorded as frequently as technically feasible. Fifty percent of rats received an oral cysteine supplementation to verify/refute the hypothesis that the incapacitation observed in previous studies is the cause of emaciation and associated impairment of CS(2) detoxification. The findings of the first study are consistent with this hypothesis, namely, that soluble Zn triggers a series of pulmonary events that is consistent with the homeostasis of this essential metal. It is concluded, accordingly, that the adjusted maximal workplace level for ZnO is also valid for propineb to preclude Zn-mediated responses to occur in the lung. With respect to muscular effects, this mechanistic study demonstrates further that the increased detoxification capacity afforded by oral supplementation of cysteine mitigates markedly the toxic potency of propineb. Procedural variables specific to the inhalation bioassay appear to be decisive for the elicitation of muscular effects. The major variable is considered to be the large drop in body weights associated with each exposure session and the concomitantly decreased uptake of essential nutritional factors (e.g., cysteine) involved in the detoxification of this compound. Accordingly, the muscular deficits elicited by high concentrations of propineb are viewed to be secondary effects in an animal species likely to be more susceptible to this type of change than humans (Pauluhn & Rosenbruch, 2003).
Asunto(s)
Zineb/análogos & derivados , Zineb/toxicidad , Administración por Inhalación , Animales , Relación Dosis-Respuesta a Droga , Femenino , Pulmón/efectos de los fármacos , Pulmón/patología , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Ratas , Ratas Wistar , Óxido de Zinc/toxicidad , Zineb/administración & dosificaciónRESUMEN
Genotoxic effects of air contaminants, such as gaseous or particulate compounds, have been difficult to investigate due to inefficient methods for exposing cell cultures directly to these substances. New cultivation and exposure techniques enable treatment of epithelial cells with sample atmospheres with subsequent in vitro assays, as demonstrated by a new system called CULTEX (CULTEX: patent No. DE 19801763; PCT/EP99/00295), which uses a transwell membrane technique for direct exposure of complex mixtures, for example sidestream cigarette smoke, at the air/liquid interface. The sensitivity and susceptibility of human bronchial epithelial cells to this complex mixture have already been shown for cytotoxic endpoints. In this study, genotoxic effects of sidestream cigarette smoke at different concentrations were assessed using the alkaline comet assay. HFBE 21 cells were exposed for 1 h to clean air, nitrogen dioxide or sidestream smoke. Exposure of the cells to sidestream cigarette smoke induced DNA strand breaks in a dose-dependent manner. The combination of gas phase exposure and the comet assay provides a realistic and efficient model for sensitive detection of DNA strand breaks induced by airborne and inhalable compounds.
Asunto(s)
Bronquios/patología , Células Epiteliales/patología , Mutágenos/toxicidad , Contaminación por Humo de Tabaco/efectos adversos , Bronquios/efectos de los fármacos , Bronquios/metabolismo , Recuento de Células , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ensayo Cometa , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Humanos , Dióxido de Nitrógeno/toxicidad , Contaminación por Humo de Tabaco/análisisRESUMEN
This article addresses results from a single 4-h and repeated 1- and 4-wk inhalation exposure studies in Wistar rats with vapor and/or aerosol atmospheres of 4-ethoxyaniline (p-phenetidine). Groups of 10 rats/sex were exposed nose-only to mean analytical concentrations of 11.1, 86.2, and 882.6 mg p-phenetidine/m(3) using an exposure regimen of 6 h/day, 5 days/wk for 4 wk. Concentrations were selected based on results from a pilot study in which rats were exposed under identical conditions on 5 consecutive days for 6 h/day to mean analytical concentrations of 38.2, 133.0, and 1247.6 mg/m(3). In repeated exposure studies, the focus of endpoints was on hematotoxicity. The LC50 was not determined, but no rats died following a single 4-h exposure to 5085 mg/m(3) as a mixture of vapor and aerosol. No mortality was observed either in the 1- or 4-wk studies. Rats exposed to 882.6 mg/m(3) and above evoked characteristic signs of toxicity that included cyanosis, with no apparent progression of findings during the exposure period. Animals exposed to 86.2 mg/m(3) and above exhibited a concentration-dependent, significant increase in blood methemoglobin and reticulocyte counts as well as a significant decrease in hemoglobin, hematocrit, and red blood cell counts. Spleen weights were significantly increased in groups exposed to 133.0 mg/m(3) and above. Microscopic changes demonstrated an increased hematopoiesis (bone marrow smears) and splenic hemosiderosis at 86.2 and 882.6 mg/m(3) and a hepatic hemosiderosis only at 882.6 mg/m(3). These data suggest that the toxicity of p-phenetidine is similar to that of its structural analog aniline. Based on the erythrocytotoxicity occurring at 86.2 mg/m(3) and above, including the apparent reactive changes in bone marrow (increased erythropoiesis) and spleen (increased erythroclasia), the no-observed-adverse-effect level (NOAEL) of the 4-wk study was 11.1 mg/m(3) air and that of the 1-wk study was 38.2 mg/m(3) air. This difference in NOAELs is considered to be related to the selection of exposure concentrations rather than cumulative toxicity.
Asunto(s)
Hematopoyesis/efectos de los fármacos , Fenetidina/efectos adversos , Aerosoles , Animales , Médula Ósea/efectos de los fármacos , Médula Ósea/fisiología , Relación Dosis-Respuesta a Droga , Femenino , Exposición por Inhalación , Masculino , Metahemoglobina/análisis , Nivel sin Efectos Adversos Observados , Fenetidina/administración & dosificación , Ratas , Ratas Wistar , Recuento de Reticulocitos , Bazo/efectos de los fármacos , Bazo/fisiología , Factores de Tiempo , VolatilizaciónRESUMEN
A Panel of medical and veterinary pathologists reviewed published and unpublished reports dealing with studies of various white mineral oils and waxes in F344 and Sprague-Dawley rats. They also had available and studied histologic slides from both subchronic and chronic studies of certain mineral hydrocarbons (90-day oral study of low melting point wax (LMPW) in female Fischer 344 and Sprague-Dawley rats; 90-day studies of P15H* and P70H white oil and high melting point wax (HMPW) in male and female F344 rats and 24 month study of P70H white oil in male and female F344 rats. The Panel also reviewed mineral oil-induced alterations in tissues of human patients (liver, hepatic lymph node and spleen). The Panel agreed that certain of the mineral hydrocarbons produced lesions in the mesenteric lymph nodes and liver of the F344 rat and these lesions were best described as microgranulomas/granulomas. The lesions were fundamentally similar in both organs, although varying in severity with dose and type of mineral hydrocarbons. The Panel agreed that hepatic lesions with inflammatory cell infiltration, necrosis, and fibrosis were produced only by feeding of LMPW and the lesions were confined to F344 rats and not found in Sprague-Dawley rats. The most severe granulomatous lesions in the mesenteric lymph nodes were found in high dose LMPW-fed F344 rats. The microgranulomas were similar in subchronic and chronic studies. Also, little difference existed between controls and treated F344 rats in the incidence and severity of the lesions after 2 years of feeding P70H white oil. The Panel agreed that some slight reversibility existed for these lesions, but also agreed that complete resolution was unlikely as regression of the lesions in the rat would likely be slow. The Panel agreed that a minimal severity infiltrate of mononuclear inflammatory cells occurred in the base of the mitral valve in a slightly increased incidence in F344 rats fed LMPW. The Panel concluded that these mitral valve alterations had little if any toxicologic significance as the focal infiltrate was minimal in severity, occurred in controls, occurred in association with murine cardiomyopathy, and were unlike the responses in the liver and mesenteric lymph nodes. The Panel agreed that the lesions observed in the liver and mesenteric lymph nodes of F344 rats exposed to MHCs, especially the LMPW, were different morphologically from changes observed in lymph node, liver, and spleen of humans that were mineral oil-users. These changes in humans are usually found incidentally in tissues taken at biopsy or autopsy. The MHC-induced lesions can be considered incidental and inconsequential in humans.
Asunto(s)
Hígado/efectos de los fármacos , Ganglios Linfáticos/efectos de los fármacos , Aceite Mineral/toxicidad , Ceras/toxicidad , Animales , Dieta , Femenino , Granuloma/inducido químicamente , Granuloma/patología , Humanos , Hígado/patología , Ganglios Linfáticos/patología , Masculino , Mesenterio/efectos de los fármacos , Mesenterio/patología , Aceite Mineral/administración & dosificación , Ratas , Ratas Endogámicas F344 , Ratas Sprague-Dawley , Especificidad de la Especie , Bazo/efectos de los fármacos , Bazo/patologíaRESUMEN
In toxicologic testing or experimental studies using animals, an adequate knowledge of spontaneously occurring lesions is required. 144 male and 184 female untreated Syrian golden hamsters (strain Han:AURA) were kept for life under standard laboratory conditions and an investigation of non-neoplastic lesions in relationship to the lifespan was performed. The average lifespan of the males was 106 weeks and that of the female hamsters 97 weeks. While cartilage degeneration of the sternum and fatty degeneration of the femoral bone marrow occurred already in the first half of life with high incidence, the majority of lesions were observed in the second half. The most frequent non-neoplastic changes in various organs were fatty change, calcification, cystic change, hyperplasia and amyloidosis. Such spontaneous lesions were discussed in connection with the same alterations which can also be induced by chemical or hormonal agents.
Asunto(s)
Envejecimiento/patología , Mesocricetus/fisiología , Enfermedades de los Roedores/patología , Envejecimiento/efectos de los fármacos , Envejecimiento/fisiología , Animales , Animales Endogámicos , Cricetinae , Femenino , Esperanza de Vida , Longevidad/efectos de los fármacos , Longevidad/fisiología , Masculino , Valores de Referencia , Enfermedades de los Roedores/inducido químicamenteRESUMEN
This article addresses results of two 13-wk inhalation toxicity studies in Wistar rats with aerosolized 1,6-hexamethylene diisocyanate (HDI) homopolymers using either the isocyanurate (HDI-IC) type or biuret (HDI-BT) type. Groups of 10 rats/sex/level were exposed nose-only to breathing zone concentrations of 0.5, 3.3, and 26.4 mg HDI-IC/m(3) or 0.4, 3.4, and 21.0 mg HDI-BT/m(3) (MMAD = 1.4-3.3 microm). The exposure regimen was 6 h/day, 5 days/wk for 13 wk. Two control groups were used in each study; one was exposed to filtered air, and the other to the vehicle acetone. In subacute pilot studies, groups of rats were exposed under identical conditions for 3 consecutive weeks using concentrations of approximately 4, 15-18, and 77-90 mg homopolymer/m(3). All studies demonstrated that adverse effects were caused by irritation-related responses occurring predominantly in the lower respiratory tract. Following subchronic exposure, compound-related effects were found only at the highest concentrations used and were confined to mild respiratory distress, marginally decreased body weights, and increased lung weights. Hematological evaluation showed a marginal increase in leukocyte counts. Pulmonary function testing revealed minimal changes indicative of increases in functional residual capacity and total lung capacity but without evidence of increased bronchial hyperreactivity to acetylcholine aerosol. Histopathology demonstrated an increased recruitment of alveolar macrophages, focal interstitial fibrosis with round-cell infiltrations, and bronchiolo-alveolar proliferations at the high-level exposure groups. The no-observable-adverse-effect levels (NOAELs) of both the 3- and 13-wk studies were in the range of 3-4 mg/m(3). Appreciable differences between the two types of polyisocyanates were not observed.
Asunto(s)
Contaminantes Ocupacionales del Aire/toxicidad , Cianatos/toxicidad , Pulmón/efectos de los fármacos , Administración por Inhalación , Aerosoles , Animales , Líquido del Lavado Bronquioalveolar/citología , Relación Dosis-Respuesta a Droga , Femenino , Isocianatos , Leucocitos/efectos de los fármacos , Leucocitos/patología , Pulmón/metabolismo , Pulmón/patología , Pulmón/fisiopatología , Macrófagos Alveolares/efectos de los fármacos , Macrófagos Alveolares/metabolismo , Masculino , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos/efectos de los fármacos , Proyectos Piloto , Ratas , Ratas Wistar , Pruebas de Función Respiratoria , Organismos Libres de Patógenos EspecíficosRESUMEN
One-hundred-and-forty-four male and 184 female untreated Syrian golden hamsters (strain Han:AURA) were kept for life under standard laboratory conditions. They were examined with regard to spontaneously occurring tumours in relation to their survival periods. The mean survival rate of the males was 106 +/- 26 weeks and that of the females 97 +/- 20 weeks. Tumours were found in 71% of males and 67% of females. Adenomas and carcinomas of the adrenal glands were the most frequently observed tumours in both sexes (male: 66%; female: 38%) and in the early stages of life. Malignant lymphoma (8%), adenomas and carcinomas of pancreatic islet-cells (8%) and papillomatous benign and malignant squamous cell tumours of the forestomach (7%) showed relatively high incidences in males, whilst in females, leiomyoma (10%) and endometrial adenocarcinoma (7%) of the uterus and adenomas and carcinomas in the pars distalis of the pituitary gland (9%) occurred frequently.
Asunto(s)
Mesocricetus , Neoplasias/veterinaria , Enfermedades de los Roedores/epidemiología , Animales , Cricetinae , Femenino , Esperanza de Vida , Longevidad , Masculino , Neoplasias/mortalidad , Neoplasias/patología , Tasa de SupervivenciaRESUMEN
Alterations in expression of the p53 and cyclin D1 genes have been implicated in the development of esophageal carcinomas in both humans and animal models. We hypothesize that altered expression of cyclin D1 and p53 may be involved in the sequential development of esophageal carcinomas with glandular differentiation induced by the carcinogen, 2,6-dimethylnitrosomorpholine (DMNM) in rats with duodenal content reflux esophagitis. In the present study Sprague-Dawley rats were given DMNM 15 days after performing an esophago-jejunostomy in order to induce chronic duodenal content reflux esophagitis. Expression and localization of p53, cyclin D1 and Ki-67 were examined by immunohistochemical analyses. Twenty of 24 animals developed different types of esophageal carcinomas, including pure squamous carcinoma, adenosquamous carcinoma and pure adenocarcinoma. Undifferentiated basaloid areas were frequently observed in these tumors. Cyclin D1 overexpression was observed in hyperplastic lesions and increased through dysplasia and in undifferentiated areas of infiltrating carcinoma. Cyclin D1 expression coincided with increased Ki-67 expression and decreased along with cell differentiation. The p53 immunohistochemical pattern was parallel to that of cyclin D1, although the percentage of positive cells was usually smaller in all lesions and increased p53 expression started at the dysplastic stage. These findings suggest that overexpression of cyclin D1 may be an early event in DMNM-induced rat esophageal tumorigenesis, causing increased proliferation of esophageal stem cells. Abnormal p53 expression may then be required to promote the development of neoplastic transformation from dysplastic epithelium through invasive phenotype, being more evident in cancer cells with squamous differentiation.
Asunto(s)
Adenocarcinoma/metabolismo , Carcinoma Adenoescamoso/metabolismo , Carcinoma de Células Escamosas/metabolismo , Ciclina D1/metabolismo , Reflujo Duodenogástrico/complicaciones , Neoplasias Esofágicas/metabolismo , Quinoxalinas/toxicidad , Proteína p53 Supresora de Tumor/metabolismo , Adenocarcinoma/inducido químicamente , Adenocarcinoma/patología , Animales , Carcinoma Adenoescamoso/inducido químicamente , Carcinoma Adenoescamoso/patología , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/patología , División Celular , Neoplasias Esofágicas/inducido químicamente , Neoplasias Esofágicas/patología , Esofagectomía , Femenino , Técnicas para Inmunoenzimas , Yeyunostomía , Antígeno Ki-67/metabolismo , Masculino , Ratas , Ratas Sprague-DawleyRESUMEN
Highly standardized and controlled inhalation studies are required for hazard identification to make test results reproducible and comparable and to fulfill general regulatory requirements for the registration of new drugs, pesticides, or chemicals. Despite significant efforts, the results of inhalation studies have to be analyzed judiciously due to the great number of variables. These variables may be related to technical issues or to the specific features of the animal model. Although inhalation exposure of animals mimics human exposure best, ie, error-prone route-to-route extrapolations are not necessary, not all results obtained under such very rigorous test conditions may necessarily also occur under real-life exposure conditions. Attempts are often made to duplicate as closely as possible these real-life exposure conditions of humans in appropriate bioassays. However, this in turn might affect established baseline data, rendering the interpretation of new findings difficult. In addition, specific use patterns, eg, of inhalation pharmaceuticals or pesticide-containing consumer products, may impose test agent-specific constraints that challenge traditional approaches. Moreover, specific modes of action of the substance under investigation, the evaluation of specific endpoints, or the clarification of equivocal findings in common rodent species may require exposure paradigms or the use of animal species not commonly used in inhalation toxicology. However, particularly in inhalation toxicology, the choice of animal models for inhalation toxicity testing is usually based on guideline requirements and practical considerations, such as exposure technology, expediency, and previous experience rather than validity for use in human beings. Larger animal species, apart from the welfare aspects, may require larger inhalation chambers to accommodate the animals, but for technical reasons and the difficulty of generating homogeneous exposure atmospheres in such inhalation chambers, this may jeopardize the outcome of the study. Some of the many variables and possible artifacts likely to occur in animal inhalation studies are addressed in this paper.
Asunto(s)
Administración por Inhalación , Pruebas de Toxicidad/métodos , Animales , Modelos Animales de Enfermedad , Pruebas de Función Respiratoria/métodos , Órganos de los Sentidos/efectos de los fármacos , Órganos de los Sentidos/fisiopatología , Especificidad de la Especie , Toxicología/legislación & jurisprudenciaRESUMEN
Although CBA mice are occasionally used in biomedical research, little is known about their life-data and diseases ("background pathology"). Therefore, it was the aim of this study to determine the life expectancy, spectrum and incidence of spontaneous neoplasms of the inbred CBA/J mouse strain. A total of 631 untreated mice (293 females; 338 males) were kept from birth to death under standard laboratory conditions. A complete histological examination was performed on all organs/tissues. In female CBA mice, the average lifespan was 94 weeks, while the mean age in males was 85 weeks. Neoplastic lesions were observed in 70% (238/338) of the males and 51% (150/293) of the female CBA/J mice. Tumours of the liver, lung and haematopoietic tissue were common in males, while tumours of the lung, ovary and haematopoietic tissue were the most frequent neoplasms in female CBA/J mice.
Asunto(s)
Ratones Endogámicos CBA , Neoplasias/veterinaria , Enfermedades de los Roedores/epidemiología , Animales , Femenino , Neoplasias Hematológicas/epidemiología , Neoplasias Hematológicas/veterinaria , Neoplasias Hepáticas/epidemiología , Neoplasias Hepáticas/veterinaria , Neoplasias Pulmonares/epidemiología , Neoplasias Pulmonares/veterinaria , Masculino , Ratones , Neoplasias/epidemiología , Neoplasias Ováricas/epidemiología , Neoplasias Ováricas/veterinaria , Caracteres SexualesRESUMEN
The assessment of cytotoxicity of air contaminants such as gaseous or particulate compounds and complex mixtures has traditionally involved animal experiments, due to the difficulties in exposing cell cultures directly to these substances. New cultivation and exposure techniques enhance the efficiency of in vitro studies, as demonstrated by a new experimental system called CULTEX which allows direct exposure of cells at the air/liquid interface. In this case, human bronchial epithelial cells are cultivated on porous transwell membranes in a device allowing intermittent medium supply. The medium is pumped into a special modular culture unit through the transwell membrane supporting the cells. At certain time intervals, the medium is completely removed and the cells can be maintained and exposed at the air/liquid interface until the next medium supply without loss of viability. In comparison to conventional submersed culture conditions, the cells have been grown on transwell membranes using the new pulse submersion technique. There are no deleterious effects on cell viability due to the direct exposure to airborne pollutants. Thus, the introduction of these new cultivation and exposure techniques offers new testing strategies for the toxicological evaluation of inhalable soluble and inert substances as well as complex mixtures.
Asunto(s)
Contaminantes Atmosféricos/toxicidad , Técnicas de Cultivo de Célula/métodos , Sistema Respiratorio/citología , Sistema Respiratorio/efectos de los fármacos , Bronquios/citología , Bronquios/efectos de los fármacos , Técnicas de Cultivo de Célula/instrumentación , Medios de Cultivo , Células Epiteliales/efectos de los fármacos , Aceites Combustibles/toxicidad , Humanos , Temperatura , Titanio/administración & dosificación , Titanio/toxicidadRESUMEN
Gene therapy using vector-mediated transfer of prodrug activating genes is a promising treatment approach for malignant tumors. As demonstrated recently, the novel prodrug activating gene coding for rabbit cytochrome P450 4B1 (CYP4B1) is able to induce tumor cell death at low micromolar concentrations in glioblastoma cells after treatment with the prodrug 4-ipomeanol (4-IM) in vitro and in vivo. The rabbit CYP4B1 converts this prodrug and other furane analogs and aromatic amines, such as 2-aminoanthracene, to highly toxic alkylating metabolites, whereas the human isoenzyme exhibits only minimal enzymatic activity. In the present study, the cDNA encoding rabbit CYP4B1 was used for pharmacogene therapy of hepatocellular carcinoma (HCC). Cell clones derived from the human HCC cell lines Hep3B, HuH-7, and HepG2 and stably expressing the chimeric protein CYP4B1-EGFP (the CYP4B1 coding sequence fused to the enhanced green fluorescent protein (EGFP) gene) were selected. HCC clones expressing EGFP served as controls. 4-IM rapidly induced tumor cell death in CYP4B1-EGFP-expressing clones at low concentrations (a 50% lethal dose of between 0.5 and 2 microg/mL). No signs of toxicity were found in control cells expressing EGFP even at high prodrug concentrations (20 microg/mL). Cell death occurred by apoptosis and was independent of functional p53. A pronounced direct bystander effect was observed in Hep3B cells, whereas bystander HepG2 and HuH-7 cells were highly resistant to toxic 4-IM metabolites. These results demonstrate that the CYP4B1/4-1M system efficiently and rapidly induces cell death in HCC cells, and that a cell line-specific mechanism may exist that limits the extent of the bystander effect of this novel prodrug activating system.
Asunto(s)
Antineoplásicos/uso terapéutico , Hidrocarburo de Aril Hidroxilasas , Carcinoma Hepatocelular/tratamiento farmacológico , Sistema Enzimático del Citocromo P-450/genética , Terapia Genética , Neoplasias Hepáticas/tratamiento farmacológico , Profármacos/uso terapéutico , Terpenos/uso terapéutico , Animales , Apoptosis , Carcinoma Hepatocelular/enzimología , Supervivencia Celular , Sistema Enzimático del Citocromo P-450/metabolismo , Relación Dosis-Respuesta a Droga , Regulación de la Expresión Génica , Proteínas Fluorescentes Verdes , Humanos , Immunoblotting , Neoplasias Hepáticas/enzimología , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Farmacogenética , Conejos , Células Tumorales CultivadasRESUMEN
The impact of particle size of aerosolized polymeric diphenylmethane-4,4'-diisocyanate (MDI) for the induction and elicitation of respiratory sensitization was evaluated. Four groups of 16 female guinea pigs each received either the vehicle, repeated intradermal (id) injections (3 x 0.3% MDI), one high-level inhalation exposure of 15 min to 135 mg MDI/m(3) air using a small aerosol (MMAD approximately 1.7 microm) or large aerosol (MMAD approximately 3.8 microm). Three weeks later, animals were challenged subsequently with two ramped concentrations of MDI aerosol (average concentrations 16 and 49 mg/m(3) air, each for 15 min) and two different particle sizes, i.e., the MMAD was either approximately 1.6 microm or approximately 5.1 microm for the small- and large-size aerosol, respectively. Respiratory sensitization was assessed by two endpoints: the measurement of respiratory rate, and examination of influx of eosinophilic granulocytes into the mucosa and submucosa of the trachea, bronchi, and lung-associated lymph nodes (LALN). The recruitment of eosinophilic granulocytes into bronchial tissues was subdivided as follows: muscularis mucosae, submucosa, and perivascular. From measurements of respiratory rate, it would appear that guinea pigs sensitized by id injections or by inhalation exposure with the large aerosol tended to display a higher responsiveness than naive controls when challenged with the small aerosol. The recruitment of eosinophilic granulocytes in the bronchial tissue was greater in both inhalation induction groups as compared to the vehicle control. It appears that there was a somewhat greater response in animals sensitized by id injections or by inhalation exposure with the large aerosol and challenged with the small aerosol. Topographically, this difference was apparent only at the bronchial perivascular level and lung-associated lymph nodes (LALN), whereas at the submucosal and muscularis mucosae level the impact on particle size tended to be less pronounced. In summary, this study suggests that a brief, high-level inhalation exposure of MDI aerosol caused a sensitization of bronchial tissues in guinea pigs. The higher sensitization potency of the large aerosol may possibly be related to a dosimetric phenomenon because of the greater fraction of deposition of large particles within the upper respiratory tract. Overall, challenge exposures with this type of irritant aerosol appear to evoke more consistent effects when the MMAD is in the range of approximately 2 rather than approximately 5 microm.
Asunto(s)
Alérgenos , Isocianatos/toxicidad , Hipersensibilidad Respiratoria/inducido químicamente , Administración por Inhalación , Aerosoles , Animales , Ensayo de Inmunoadsorción Enzimática , Eosinofilia/inducido químicamente , Eosinofilia/patología , Eosinófilos/efectos de los fármacos , Eosinófilos/patología , Femenino , Cobayas , Inmunoglobulina G/biosíntesis , Inyecciones Intradérmicas , Isocianatos/inmunología , Tamaño de la Partícula , Respiración/efectos de los fármacos , Hipersensibilidad Respiratoria/fisiopatología , Mucosa Respiratoria/citología , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/patologíaRESUMEN
The pulmonary response of Wistar rats to respirable polymeric diphenylmethane-4,4'-diisocyanate (PMDI) aerosol was examined in a 2-wk repeated nose-only inhalation exposure study. Exposure concentrations were 1.1, 3.3, and 13.7 mg PMDI/m(3) (6 h/day, 15 exposures). The level of 13.7 mg/m(3) was actually a combination of an initial target concentration of 10 mg/m(3) in wk 1, which was raised to 16 mg/m(3) in wk 2, due to a lack of signs suggestive of pulmonary irritation. An acute sensory irritation study on rats served as basis for selection of these concentrations. Shortly after the 2-wk exposure period, rats were subjected to pulmonary function and arterial blood gas measurements. Lungs were examined by light and transmission electron microscopy, and labeling indices in terminal bronchioles were measured. Bronchoalveolar lavage (BAL) was performed to assess various indicators of pulmonary inflammation, including neutrophil and macrophage numbers, protein, lactate dehydrogenase (LDH), gamma-glutamyltranspeptidase (gamma-GT), alkaline phosphatase (APh), acid phosphatase (ACPh), and beta-N-acetylglucosaminidase (beta-NAG). Phosphatidylcholine in BAL fluid and BAL cells was determined as aggregated endpoint suggestive of changes in pulmonary surfactant. Rats exposed to 3.3 and 13.7 mg/m(3) experienced concentration-dependent signs of respiratory tract irritation. Determination of arterial blood gases, lung mechanics, and carbon monoxide diffusing capacity did not demonstrate specific effects. Analysis of BAL fluid and BAL cells revealed changes indicative of marked inflammatory response and/or cytotoxicity in rats exposed to 13.7 mg/m(3), and the changes were characterized by statistically significantly increased activities of LDH, beta-NAG, and protein. Phospholipid concentrations were increased in rats exposed to 1.1 mg/m(3) and above (elevated levels of lipid material in alveolar macrophages demonstrated by polychrome stain) and 3.3 mg/m(3) and above (increased intracellular ACPh activity and intracellular phospholipids). In these groups, gamma-GT was statistically significantly increased. These findings suggest that changes in phospholipid homeostasis appear to occur at lower levels than those eliciting inflammation and cytotoxicity. Light and transmission electron microscopy suggest that exposure to 3.3 and 13. 7 mg/m(3) resulted in focal inflammatory lesions and an accumulation of refractile, yellowish-brownish material in alveolar macrophages with concomitant activation of type II pneumocytes. In the terminal bronchioles a concentration-dependent increase of bromodeoxyuridine (BrdU)-labeled epithelial cells was observed in all PMDI exposure groups. In summary, it appears that respirable PMDI aerosol interacts with pulmonary surfactant, which, in turn, may stimulate type II pneumocytes to increase their production of surfactant and to proliferate.
Asunto(s)
Alérgenos/toxicidad , Exposición por Inhalación/efectos adversos , Isocianatos/toxicidad , Enfermedades Pulmonares/inducido químicamente , Enfermedades Pulmonares/patología , Poliuretanos/toxicidad , Animales , Cámaras de Exposición Atmosférica , Biomarcadores , Análisis de los Gases de la Sangre , Peso Corporal/efectos de los fármacos , Bronquiolitis/inducido químicamente , Bronquiolitis/patología , Líquido del Lavado Bronquioalveolar , Replicación del ADN/efectos de los fármacos , Femenino , Isocianatos/administración & dosificación , Enfermedades Pulmonares/metabolismo , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Wistar , Pruebas de Función Respiratoria , Mecánica Respiratoria/efectos de los fármacos , Relación Ventilacion-PerfusiónAsunto(s)
Muerte Celular , Terminología como Asunto , Animales , Apoptosis , Guías como Asunto , Humanos , Necrosis , Patología Clínica , Sociedades Científicas , ToxicologíaRESUMEN
In 2 lifespan transgeneration experiments using a total of 4,682 CBA/J mice, we observed uncommon lipomatous lesions in the livers of 8 mice independent of the treatment. Macroscopically, the lesions were described as pale white areas (2) or nodules (6) during necropsy. The lesions ranged from 1 to 15 mm in diameter. Microscopically, the lesions consisted of nodular aggregations of round to spindle-shaped cells that partly caused distinct compression of the adjacent hepatic parenchyma. The tumor cells were smaller than hepatocytes and had dark oval nuclei. Many of the more spherical cells contained clear vacuoles of various sizes, which were shown to be lipid droplets by oil red O staining. In addition to Gomori's silver and Masson's trichrome staining, several immunohistochemical stains were used to characterize the origin of the proliferating cells. Tumor cells were labeled by vimentin, actin, desmin, and proliferating cell nuclear antigen. The 2 cell phenotypes showed similar staining characteristics. Increased amounts of laminin and tenascin, 2 extracellular matrix proteins of the liver, were detected within these neoplasms. Summarizing, we suggest that these tumors are of Ito cell origin.
Asunto(s)
Adenocarcinoma/patología , Macrófagos del Hígado/patología , Neoplasias Hepáticas/patología , Enfermedades de los Roedores/patología , Adenocarcinoma/genética , Adenocarcinoma/metabolismo , Adipocitos/metabolismo , Adipocitos/patología , Animales , Biomarcadores de Tumor/análisis , Femenino , Técnicas para Inmunoenzimas , Macrófagos del Hígado/metabolismo , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Masculino , Ratones , Ratones Endogámicos CBA , Embarazo , Enfermedades de los Roedores/genética , Enfermedades de los Roedores/metabolismoRESUMEN
A subacute nose-only inhalation study with low (approximately 3%), medium (approximately 40%), and high humidity (approximately 80%) has been performed on young adult Wistar rats. Exposure was 6-hr/day on 5 days/week for 4 consecutive weeks. Rats housed individually in the animal holding room, deprived of feed and water during exposure of the remaining groups, served as concurrent controls (sham controls). This study served the purpose to assess whether toxicologically significant effects occur when rats are repeatedly exposed to lower or higher humidity chamber atmospheres than proposed by current testing guidelines. For analysis, conventional end-points as required by common testing guidelines were considered, i.e., clinical observations before and after exposure, rectal temperatures, body weights, feed and water consumption. At the end of the 4-week exposure period, ophthalmological and gross pathological examinations were made and major organ weights determined. The histopathological examinations comprised the nasal cavities, larynx, trachea, and lungs. There was no apparent evidence of humidity-related effects on nose-only exposed rats. When compared with non-exposed sham controls, however, body weights, water and feed consumption were markedly reduced in all nose-only exposure groups. In summary, it can be concluded that rats tolerated either humidity atmosphere without any specific effects. As far as there were differences to sham controls they appear to be more controlled by the differences in the exposure patterns (nose-only versus normal housing) than differences in the humidity of chamber atmospheres. Thus, deviations of current testing guidelines for repeated exposure inhalation studies with regard to humidity, do not appear to have any appreciable impact on the study outcome.